Støer NC, Botteri E, Lindemann K, Langseth H, Fortner RT (2025)
Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway
BMC Cancer, 25 (1), 807
DOI 10.1186/s12885-025-14168-y, PubMed 40307814

Poveda A, Lheureux S, Colombo N, Cibula D, Elstrand M, Weberpals J, Bjurberg M, Oaknin A, Sikorska M, González-Martín A, Madry R, Rubio Pérez MJ, Ledermann J, Romero I, Özgören O, Barnicle A, Marshall H, Bashir Z, Škof E (2025)
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial
Gynecol Oncol, 197, 74-82 (in press)
DOI 10.1016/j.ygyno.2025.04.580, PubMed 40300425

Bjerre Trent P, Leitzinger N, Wang Y, Dahl GF, Eyjólfsdóttir B, Dahl JF, Lund KV, Staff AC, Falk RS, Eriksson AGZ (2025)
The detection rate of metastatic lymph nodes comparing sentinel lymph node biopsy and lymphadenectomy for staging of intermediate- and high-risk endometrial carcinoma
Int J Gynecol Cancer, 35 (5), 101810 (in press)
DOI 10.1016/j.ijgc.2025.101810, PubMed 40288097